Protein Alternatives

About:

ProAlt is young biotech company developing innovative products for the detection and treatment of cancers.

Website: http://www.proteinalternatives.com/

Twitter/X: ProAlt2006

Top Investors: EASME - EU Executive Agency for SMEs

Description:

ProAlt is young biotech company developing innovative products for colorectal cancer early diagnosis in blood and novel therapeutic antibodies for the treatment of colon, breast and melanoma metastatic tumors. The company also offers its own manufactured recombinant proteins and antibodies, and different custom-tailored services in protein and antibodies design and manufacturing (CRO/CMO).

Total Funding Amount:

2.31M EUR

Headquarters Location:

Madrid, Madrid, Spain

Founded Date:

2006-01-01

Contact Email:

info(AT)proteinalternatives.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2015-10-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai